Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-05-01 Purchase | 2024-05-02 4:50 pm | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 26,526 | $13.46 | $356,929 | 3,068,730 (Indirect) | View |
2024-04-30 Purchase | 2024-05-01 10:23 am | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 16,573 | $13.13 | $217,603 | 3,042,204 (Indirect) | View |
2024-04-26 Purchase | 2024-04-29 4:54 pm | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 120,304 | $13 | $1,563,952 | 3,025,602 (Indirect) | View |
2024-04-24 Purchase | 2024-04-26 11:40 am | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 118,103 | $13.01 | $1,536,827 | 2,905,298 (Indirect) | View |
2024-04-22 Purchase | 2024-04-23 8:00 pm | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 50,225 | $13.14 | $659,913 | 2,787,195 (Indirect) | View |
2024-04-18 Purchase | 2024-04-22 3:08 pm | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 124,197 | $12.81 | $1,591,420 | 2,736,970 (Indirect) | View |
2024-04-09 Purchase | 2024-04-12 09:20 am | abrdn Life Sciences Investors | HQL | Goetz Kathleen Director | 400 | $13.32 | $5,327 | 1,085 (Direct) | View |
2024-01-02 Purchase | 2024-01-04 2:23 pm | abrdn Life Sciences Investors | HQL | Reit Todd Director | 1,000 | $13.8 | $13,798 | 1,000 (Direct) | View |
2023-12-28 Purchase | 2024-01-02 4:34 pm | abrdn Life Sciences Investors | HQL | Maher Bill Director | 1,000 | $13.57 | $13,570 | 1,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2024-04-19 08:05 am | N/A N/A | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 0 | $0 | 2,694,511 (Indirect) | View |